收藏切换
Study on mechanism of action of Danlou tablets in treating diabetic cardiomyopathy based on network pharmacology and validation of RAGE/NF-κB/NLRP3 signaling pathway
收藏切换
Xiaoqiang NAN1, Yanli WANG2, Xiaofan JIANG1, Peng LEI1, Juane LI1, *
World Clinical Drug | 2023, 44(10) : 1034 - 1042
Less
收藏切换
World Clinical Drug | 2023, 44(10): 1034-1042
• Article •
Study on mechanism of action of Danlou tablets in treating diabetic cardiomyopathy based on network pharmacology and validation of RAGE/NF-κB/NLRP3 signaling pathway
Full
Xiaoqiang NAN1, Yanli WANG2, Xiaofan JIANG1, Peng LEI1, Juane LI1, *
Affiliations
  • 1.Department of Traditional Chinese Medicine, Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi Province, China
  • 2.Department of Traditional Chinese Medicine, Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine, Urumqi 830000, Xinjiang Uygur Autonomous Region, China
Published: 2023-10-10 doi: 10.13683/j.wph.2023.10.004
Outline
收藏切换
Objective

To systematically evaluate the pharmacological effects and molecular mechanisms of Danlou tablets with comprehensive pharmacological strategies, and to provide a theoretical basis for the treatment of diabetic cardiomyopathy (DCM).

Methods

The chemical constituents and targets of Danlou tablets were discovered from the platform of pharmacology analysis of traditional Chinese medicine system, and the interaction network of "component-target" was established. All the targets of DCM were screened through the database, the relationship diagram of "component-disease target" was constructed. The core targets were screened, and the gene ontology analysis and the related pathway enrichment were performed on the core targets. The DCM rat model was treated with Danlou tablets to verify the predicted important signaling pathways.

Results

A total of 190 compound nodes and 275 target nodes were screened from 10 important formulations of Danlou tablet. A total of 19 targets related to DCM were screened from Danlou tablet, and 103 target related pathways had role in DCM. In vivo, Danlou tablet reduced the expression of fibrosis-related factor messenger RNA in myocardium of DCM rats and inhibited the expression of receptor for advanced glycation end products (RAGE)/nuclear factor (NF)-κB/nucleotide-binding oligomerization domain-like receptor protein (NLRP)3 pathway-related proteins RAGE and NLRP3, and phosphorylation of NF-κB (p65) protein.

Conclusion

Danlou tablets can inhibit myocardial fibrosis in DCM rats by blocking the activation of RAGE/NF-κB/NLRP3 signaling pathway, and then inhibiting the progression of the disease.

network pharmacology  /  Danlou tablet  /  diabetic cardiomyopathy  /  receptor for advanced glycation end products/nuclear factor-κB/nucleotide-binding oligomerization domain-like receptor protein 3 signaling pathway
南晓强, 王艳丽, 姜小帆, 雷鹏, 李娟娥. 基于网络药理学探讨丹蒌片治疗糖尿病心肌病的作用机制及RAGE/NF-κB/NLRP3信号通路验证. 世界临床药物, 2023 , 44 (10) : 1034 -1042 . DOI: 10.13683/j.wph.2023.10.004
Xiaoqiang NAN, Yanli WANG, Xiaofan JIANG, Peng LEI, Juane LI. Study on mechanism of action of Danlou tablets in treating diabetic cardiomyopathy based on network pharmacology and validation of RAGE/NF-κB/NLRP3 signaling pathway[J]. World Clinical Drug, 2023 , 44 (10) : 1034 -1042 . DOI: 10.13683/j.wph.2023.10.004
Year 2023 volume 44 Issue 10
17
4
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.10.004
  • Receive Date:2023-02-06
  • Online Date:2026-11-18
  • Published:2023-10-10
Article Data
Affiliations
History
  • Received:2023-02-06
Funding
Affiliations
    1.Department of Traditional Chinese Medicine, Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi Province, China
    2.Department of Traditional Chinese Medicine, Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine, Urumqi 830000, Xinjiang Uygur Autonomous Region, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.10.004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT